WuXi AppTec
WuXi AppTec Sells China-Based Clinical Research Units to Hillhouse Investment Management
WuXi AppTec; clinical services; China-based; sale; Hillhouse Investment Management; WuXi Clinical; WuXi MedKey; CRDMO strategy
WuXi AppTec Divests China Clinical Services to Hillhouse Capital, Refocuses on Manufacturing Business
WuXi AppTec; Hillhouse Capital; divestment; clinical research services; CRDMO; manufacturing; China; WuXi Clinical; MedKey